Clinical Trial Update: Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alternating maintenance therapy with fruquintinib and bevacizumab plus capecitabine after first-line treatment in metastatic colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN